Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Serruys

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 25, 2014
Performance of the resolute zotarolimus-eluting stent in small vesselsRonald Caputo, Martin Leon, Patrick Serruys, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 20, 2015
Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial ProgramMohamed Abdel-Wahab, Franz-Joseph Neumann, Patrick Serruys, et al.
The Journal of Invasive Cardiology|August 11, 2011
Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registriesCihan Simsek, Michael Magro, Eric Boersma, et al.
International Journal of Cardiovascular Interventions|March 8, 2003
Long-term clinical outcome after stent implantation in coronary arteriesPeter de Jaegere Pd, Ron van Domburg Rv, Hendrik Nathoe, et al.
European Heart Journal|November 16, 2010
One year follow-up of the multi-centre European PARTNER transcatheter heart valve studyThierry Lefèvre, Ari Pieter Kappetein, Ernst Wolner, et al.
The Journal of Invasive Cardiology|July 9, 2005
The efficacy of sirolimus-eluting stents versus bare metal stents for diabetic patients undergoing elective percutaneous coronary interventionJiro Aoki, Andrew Ong, Gaston Rodriguez-Granillo, et al.
Journal of Affective Disorders|October 29, 2011
Beta blocker therapy is associated with reduced depressive symptoms 12 months post percutaneous coronary interventionLinda C Battes, Susanne S Pedersen, Rohit M Oemrawsingh, et al.
Circulation. Cardiovascular Imaging|December 29, 2025
Coronary CTA in Contemporary Percutaneous Coronary Intervention: From Diagnostic Modality to Decision-Making ToolkitFoziyah Alqahtani, Emiliano Bianchini, Sara Alsubaie, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2011
Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarctionManel Sabaté, Angel Cequier, Andrés Iñiguez, et al.
BMC Cardiovascular Disorders|January 20, 2024
Randomized evaluation of 5-month Ticagrelor monotherapy after 1-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with drug-coated balloons: REC-CAGEFREE II trial rationale and designChao Gao, Bin Zhu, Jianzheng Liu, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 25, 2014
Performance of the resolute zotarolimus-eluting stent in small vesselsRonald Caputo, Martin Leon, Patrick Serruys, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 20, 2015
Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial ProgramMohamed Abdel-Wahab, Franz-Joseph Neumann, Patrick Serruys, et al.
The Journal of Invasive Cardiology|August 11, 2011
Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registriesCihan Simsek, Michael Magro, Eric Boersma, et al.
International Journal of Cardiovascular Interventions|March 8, 2003
Long-term clinical outcome after stent implantation in coronary arteriesPeter de Jaegere Pd, Ron van Domburg Rv, Hendrik Nathoe, et al.
European Heart Journal|November 16, 2010
One year follow-up of the multi-centre European PARTNER transcatheter heart valve studyThierry Lefèvre, Ari Pieter Kappetein, Ernst Wolner, et al.
The Journal of Invasive Cardiology|July 9, 2005
The efficacy of sirolimus-eluting stents versus bare metal stents for diabetic patients undergoing elective percutaneous coronary interventionJiro Aoki, Andrew Ong, Gaston Rodriguez-Granillo, et al.
Journal of Affective Disorders|October 29, 2011
Beta blocker therapy is associated with reduced depressive symptoms 12 months post percutaneous coronary interventionLinda C Battes, Susanne S Pedersen, Rohit M Oemrawsingh, et al.
Circulation. Cardiovascular Imaging|December 29, 2025
Coronary CTA in Contemporary Percutaneous Coronary Intervention: From Diagnostic Modality to Decision-Making ToolkitFoziyah Alqahtani, Emiliano Bianchini, Sara Alsubaie, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2011
Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarctionManel Sabaté, Angel Cequier, Andrés Iñiguez, et al.
BMC Cardiovascular Disorders|January 20, 2024
Randomized evaluation of 5-month Ticagrelor monotherapy after 1-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with drug-coated balloons: REC-CAGEFREE II trial rationale and designChao Gao, Bin Zhu, Jianzheng Liu, et al.
Pageof 11